Roche Holding | ROG - Ebitda





Ebitda تغيير تاريخ
AbbVie USD 3.69B 1.68B 2026-03
Alcon AG USD 795M 478M 2026-03
Almirall EUR 114.07M 60.37M 2025-12
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.16B 510M 2026-06
Bayer EUR 4.45B 2.49B 2026-03
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Fresenius EUR 951M 283M 2026-03
Fresenius Medical Care EUR 824M 250M 2026-03
Genmab DKK 186M 291M 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 3.51B 734M 2026-06
GRIFOLS EUR 473M 120M 2026-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.53B 87M 2026-03
Merck USD 6.3B 2.09B 2025-12
Novartis USD 6.48B 1.19B 2026-06
Orion EUR 191.9M 61.5M 2026-06
Pfizer USD 5.99B 5.23B 2026-03
Philips EUR 910M 343M 2026-06
Recordati EUR 256.6M 26.98M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
UCB EUR 1.6B 570M 2025-12